Though gender diversity is crucial for getting medicine making right, we have to stop and ask ourselves if enough is being done to address the natural differences that exist within patient populations. Historical data shows that drugs affect men and women differently, but even some of the most recent drug trials, including those for COVID-19 vaccines, have failed to thoroughly consider the impact of sex on therapeutic efficacy. In this week’s newsletter, you’ll find commentary on the topic from Ann Taylor, Chief Medical Officer at AstraZeneca, who says, “Diversity in the drug development process [...] is not a ‘nice to do.’ It’s a business – and ethical – imperative.” For Taylor’s full perspective, check out the article below.

Inclusive Drug Development
07/05/2021 | Ann Taylor
The lack of female representation in clinical trials impairs the very foundation that the development of safe and effective medicines is built upon.
Take Care of Yourself!
07/08/2021 | Maryam Mahdi
How is the OTC industry rising to pharma's biggest challenges?
Understanding the Three Levels of Genetic Medicine
07/02/2021 | James Strachan
Care must be taken to ensure patients understand the difference between gene therapy and the different kinds of gene editing.
COVID-19’s Digital Legacy
07/01/2021 | Claire Hill
Efficient data management is critical to meet the demand for fast drug development – especially in light of COVID-19
Join us to learn the importance of using GMP plasmid in early phase clinical trials

Learn more on the importance of utilizing GMP plasmid in early phase clinical trials – creating a safer product for patients, reducing risk in future regulatory filings and simplifying the supply chain and CMC plans. Find out more

White Papers
Protein stability analysis technologies for the biopharmaceutical industry

This buyer's guide discusses the available instrumentation for protein stability characterization, and what to consider when choosing stability assays. Protein stability and higher order structure is used to assist with biocomparability studies. Read more

Generic Nasal Spray Design

How spray formulations and devices interact to impact drug delivery performance. Read more

Special Promotions
Cell and Gene Therapy: Learning from the Pandemic

Discover learnings from the rapid development, approval and manufacturing of the COVID-19 vaccines can be applied to cell and gene therapy. Stream Now

Maintain consistency with reliable media manufacturing solutions

Achieving consistency when scaling up your proprietary media formulation is essential. Join forces with the trusted pioneer of scalable bioprocessing solutions for reliable cGMP media manufacturing. Find out more

We Need to Talk About Cell and Gene Therapy

Experts explain why the advanced therapy field must progress with the needs of the patient – as defined by the patient – in mind in The Medicine Maker Cell and Gene Therapy Supplement.

A dedicated cell + gene therapy newsletter from The Medicine Maker team

Join 1,000s of peers from across the pharmaceutical, investment, and regulatory sectors for expert insight, analysis and words of wisdom on everything cell + gene therapy. Subscribe Now

Must-See Events Worldwide

We work with event organizers from all around the world to help bring the pharma industry together, from large congresses to intimate meetings that fit around a table. Discover some of the events that we partner with and and stay up-to-date with the latest developments.

Find out more